|
|
Post by compound26 on Dec 10, 2015 13:20:36 GMT -5
And we know 2 of the 12 Afrezza users that presented their situation to the advisory board! I guess at least three.  Sam, Eric and most likely this guy: |
|
|
|
Post by dictatorsaurus on Dec 10, 2015 13:26:18 GMT -5
And we know 2 of the 12 Afrezza users that presented their situation to the advisory board! Sam's silence is very unsual. Could be a sign something is up. He's a huge Afrezza advocate and is well respected by the masses. This is the first time I actually feel a BO might be in the works. |
|
|
|
Post by mnholdem on Dec 10, 2015 13:34:09 GMT -5
So in conclusion, we're pleased to enter the fourth quarter with the financial resources to fully support Afrezza's operations, as well as advance MannKind's product development efforts currently in process. With these transactions, we expect to fund the company's operations into 2017, and ensure we have the staying power to realize Afrezza's potential, and also leverage the Technosphere platform into new areas.
---
While it was made clear that MannKind Corporation wanted to be listed on the TASE, I haven't seen conclusive evidence that the intent was for financing. Perhaps some would suggest that I am naïve to not think that Al had some background role in TASE purchasing shares directly. Maybe I am, but I don't believe that I'm being delusional by believing Alfred Mann likely has more than just a few friends who want to see MannKind Corporation survive.
Some might also also argue that Matt's final sentence of "ensuring staying power to realize Afrezza's potential" indicates that MannKind believes that shareholders will see that potential demonstrated in 2016. It did have the ring of a timeline to it... without violating any NDA provisions within the License & Collaboration Agreement with Sanofi.
Good fortune all! 
Mn, I would very much like to hear your opinion about the latest financing through TASE: management mistake or good move? Personally I think this is a mistake from the management and it got me very frustrated. They could have settled their bonds by issuing 20mil shares back in August when MNKD stock price still in 4s. Instead they got us in this financial mess: Low cash/sp in all time.
To me, it seems like Al Mann is simply re-arranging the cards in his hand, like when somebody else at the poker table changes the suit and your Jack of Hearts isn't worth as much anymore...
If Matt's statement is accurate (and I have no reason to believe otherwise) then I think the direct purchases of company stock from certain TASE fund managers was a show of support or friendship for Al Mann. Making a judgment of whether management made a mistake or a good move implies that Matt is lying, and that MannKind planned the direct purchases rather than being approached by TASE fund managers.
As I stated (above) I think Al's only interest is to get to a certain point where cash on hand will become a moot point. In that respect, TASE dealt him a nice card and he's playing it.
|
|
|
|
Post by mnkdfann on Dec 10, 2015 13:35:37 GMT -5
Just as a point of clarification, unless I missed something, the slides are NOT from the meeting Sanofi hosted. The very first slide shows the date and the venue. What did I miss? As I understand it, Sanofi HOSTED a meeting of early adopters and some others last weekend (first post in this thread). The slides are not from THAT meeting. The slides are from a Dec 9th meeting in La Jolla that was hosted by TCOYD. Yes, Sanofi supports TCOYD as a sponsor but so do literally dozens of other pharma and related companies. So I think it is not correct to say Sanofi "hosted" that meeting any more than, say, Lilly or Nova or Merck or Bayer etc. I may just be confused over which meeting I thought you thought the slides were from. |
|
|
|
Post by mssciguy on Dec 10, 2015 13:38:06 GMT -5
Multiple catalysts in January and the hedge funds know it. GSCO (aka SEC) is doing everything it can for itself and it's hedge fund clients to cover through dark pools. No doubt up to 80% or more of the so called "volume" is completely fake, a ruse by SEC (Sorry, GSCO) to manipulate price.
|
|
|
|
Post by dreamboatcruise on Dec 10, 2015 13:42:27 GMT -5
And we know 2 of the 12 Afrezza users that presented their situation to the advisory board! Sam's silence is very unsual. Could be a sign something is up. He's a huge Afrezza advocate and is well respected by the masses. This is the first time I actually feel a BO might be in the works. I can't imagine they would have divulged any info to Afrezza users about a pending BO at a medical advisory board meeting. That doesn't make sense. |
|
|
|
Post by EveningOfTheDay on Dec 10, 2015 13:43:59 GMT -5
On that separate issue (if I may stray for a moment) I'm wondering if suggestions that MannKind ran to the TASE for financing (above) are really painting an accurate picture. Unless he is misleading us, which I don't think he can since his remark is so easily disproven, Matt Pfeffer's statement on the matter was that it was some of the Israeli TASE fund managers who approached and asked to help MannKind directly by purchasing shares directly from the company. Many Wall ... Some might also also argue that Matt's final sentence of "ensuring staying power to realize Afrezza's potential" indicates that MannKind believes that shareholders will see that potential demonstrated in 2016. It did have the ring of a timeline to it... without violating any NDA provisions within the License & Collaboration Agreement with Sanofi.
Good fortune all.
MN, you have a very good point, I forgot some of those remarks, as what stuck to my mind was the somewhat bizarre comment about not allowing those shorting the stock to exit easily. I agree that the 2017 comment has a ring of timeline to it. If this was to be true it would also fit the timeline pushed by the vocal major shorts. They seemed to be very intent in telling us that the stock would go to 1 by December, so I wonder if they understand that as soon as it is clear that Sanofi will not be abandoning the project, the stock will become much harder to push down and covering might become impossible. In that case, this December, coinciding with end of the year tax related selling, could be the last chance they have to cover painlessly. It all does fit a pretty neat timeline, IMHO. |
|
|
|
Post by mssciguy on Dec 10, 2015 13:44:00 GMT -5
Sam's silence is very unsual. Could be a sign something is up. He's a huge Afrezza advocate and is well respected by the masses. This is the first time I actually feel a BO might be in the works. I can't imagine they would have divulged any info to Afrezza users about a pending BO at a medical advisory board meeting. That doesn't make sense. My gut feel is that a CEO has been chosen. And he or she is very good. How about you dreamboatcruise ? |
|
|
|
Post by dictatorsaurus on Dec 10, 2015 13:45:15 GMT -5
Sam's silence is very unsual. Could be a sign something is up. He's a huge Afrezza advocate and is well respected by the masses. This is the first time I actually feel a BO might be in the works. I can't imagine they would have divulged any info to Afrezza users about a pending BO at a medical advisory board meeting. That doesn't make sense. I meant he might have signed an NDA. |
|
|
|
Post by compound26 on Dec 10, 2015 13:49:34 GMT -5
I can't imagine they would have divulged any info to Afrezza users about a pending BO at a medical advisory board meeting. That doesn't make sense. I meant he might have signed an NDA. Yes, definitely. Last evening, Sam posted a tweet saying that if any PWD following him is interested in knowing how many Afrezza users (probably the ones Sam is aware of) are achieving non-diabetic numbers, he/she can send a private message to Sam. But today I noticed that Sam has removed this particular tweet. He is definitely keeping quite based on an NDA. |
|
|
|
Post by bill on Dec 10, 2015 13:50:02 GMT -5
Sam's silence is very unsual. Could be a sign something is up. He's a huge Afrezza advocate and is well respected by the masses. This is the first time I actually feel a BO might be in the works. I can't imagine they would have divulged any info to Afrezza users about a pending BO at a medical advisory board meeting. That doesn't make sense. I don't think we can infer enthusiasm from the San Diego attendees to reflect anything more than the event went as well as expected from their perspective. That may turn out to mean something, or nothing at all but it's sure better than if the attendees were bummed out when they left . |
|
|
|
Post by dreamboatcruise on Dec 10, 2015 13:50:31 GMT -5
Multiple catalysts in January and the hedge funds know it. GSCO (aka SEC) is doing everything it can for itself and it's hedge fund clients to cover through dark pools. No doubt up to 80% or more of the so called "volume" is completely fake, a ruse by SEC (Sorry, GSCO) to manipulate price. If 80% is fake shorts would still have to count on the other real 20% in order to cover real shares that have been shorted... and manipulated price or not, they've got to convince real shareholders to part with their shares at a given price. No one gets forced to turn over their shares just because the ticker is manipulated down. They don't get to reach into my account, or Al's rather huge account, and grab shares at these prices to cover. Sorry GSCO, SEC... manipulation doesn't get my shares. |
|
|
|
Post by mssciguy on Dec 10, 2015 13:53:01 GMT -5
Multiple catalysts in January and the hedge funds know it. GSCO (aka SEC) is doing everything it can for itself and it's hedge fund clients to cover through dark pools. No doubt up to 80% or more of the so called "volume" is completely fake, a ruse by SEC (Sorry, GSCO) to manipulate price. If 80% is fake shorts would still have to count on the other real 20% in order to cover real shares that have been shorted... and manipulated price or not, they've got to convince real shareholders to part with their shares at a given price. No one gets forced to turn over their shares just because the ticker is manipulated down. They don't get to reach into my account, or Al's rather huge account, and grab shares at these prices to cover. Sorry GSCO, SEC... manipulation doesn't get my shares. I think mnholdem nailed it .. let's call it GSEC that is funny... a good meme that just might go viral. Bernie Sanders would have a field day with that one.  |
|
|
|
Post by bill on Dec 10, 2015 13:53:17 GMT -5
I can't imagine they would have divulged any info to Afrezza users about a pending BO at a medical advisory board meeting. That doesn't make sense. I don't think we can infer enthusiasm from the San Diego attendees to reflect anything more than the event went as well as expected from their perspective. That may turn out to mean something, or nothing at all but it's sure better than if the attendees were bummed out when they left . Wow, that's interesting. I've always wondered whether SNY could use real-world data like that to help gain an improved label, or at least use it in their marketing. After all it is objective data, e.g., "some T1 Afrezza users have been able to achieve non-diabetic A1c values." I can't imagine anyone quibbling with that statement if it's backed up with numbers and lab reports. |
|
|
|
Post by dreamboatcruise on Dec 10, 2015 13:54:25 GMT -5
I can't imagine they would have divulged any info to Afrezza users about a pending BO at a medical advisory board meeting. That doesn't make sense. I meant he might have signed an NDA. May well have signed an NDA... likely did. I just don't understand why this meeting having patients and doctors talk about Afrezza would at all give you a reason to think that a BO is in the works. These medical advisory meetings are common practice. |
|
Sam, Eric and most likely this guy:
